Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000902664-25-002066
Filing Date
2025-05-02
Accepted
2025-05-02 06:24:53
Documents
1
Effectiveness Date
2025-05-02
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10886
  Complete submission text file 0000902664-25-002066.txt   12170
Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 (212) 937-4975
Avoro Life Sciences Fund LLC (Filer) CIK: 0001498991 (see all company filings)

EIN.: 271007273 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-146405 | Film No.: 25905400